Anli Yang
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer-related molecular mechanisms research 9
- MicroRNA in disease regulation 9
- Breast Cancer Treatment Studies 4
- Oncology 16
- Cancer Treatment and Pharmacology 4
- Co-authors
- Yutian Zou (16 shared papers)Shaoquan Zheng (16 shared papers)Hailin Tang (14 shared papers)Weikai Xiao (16 shared papers)Xinhua Xie (7 shared papers)Xiaoming Xie (7 shared papers)Xinpei Deng (6 shared papers)Jie‐Ying Liang (6 shared papers)
- Journals
- Frontiers in Immunology (3 papers)Journal of Cellular and Molecular Medicine (2 papers)Aging (2 papers)BMC Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Anli Yang
69 papers receiving 1.8k citations
Anli Yang's Hit Papers
Peers
Comparison fields: 5 of 109
- Cancer Research 630
- Oncology 299
- Molecular Biology 815
- Pulmonary and Respiratory Medicine 273
- Hepatology 50
Countries citing papers authored by Anli Yang
This map shows the geographic impact of Anli Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anli Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anli Yang more than expected).
Fields of papers citing papers by Anli Yang
This network shows the impact of papers produced by Anli Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anli Yang. The network helps show where Anli Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Anli Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 74 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 137 | |
| 2 | 2019 | 107 | |
| 3 | 2020 | 91 | |
| 4 | 2014 | 75 | |
| 5 | 2019 | 74 | |
| 6 | 2020 | 68 | |
| 7 | 2019 | 66 | |
| 8 | 2018 | 65 | |
| 9 | crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab deruxtecan resistance in HER2-low breast cancer Hit paper breakdown → | 2024 | 65 |
| 10 | 2020 | 62 | |
| 11 | 2021 | 61 | |
| 12 | 2022 | 53 | |
| 13 | 2020 | 51 | |
| 14 | 2020 | 48 | |
| 15 | 2020 | 47 | |
| 16 | 2023 | 45 | |
| 17 | 2013 | 42 | |
| 18 | 2024 | 42 | |
| 19 | 2020 | 39 | |
| 20 | 2020 | 35 |
About Anli Yang
Anli Yang is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Molecular Biology and Hepatology, having authored 74 papers that have together received 1.8k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (9 papers), MicroRNA in disease regulation (9 papers), Circular RNAs in diseases (7 papers), Ferroptosis and cancer prognosis (7 papers), Nanoplatforms for cancer theranostics (6 papers), RNA modifications and cancer (5 papers), Breast Cancer Treatment Studies (4 papers) and Cancer Treatment and Pharmacology (4 papers). The work is most often cited by research in Cancer Research (630 citations), Oncology (299 citations), Molecular Biology (815 citations), Pulmonary and Respiratory Medicine (273 citations) and Hepatology (50 citations). Anli Yang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yutian Zou, Shaoquan Zheng, Hailin Tang, Weikai Xiao, Xinhua Xie, Xiaoming Xie, Xinpei Deng, Jie‐Ying Liang, Feng Cai and Xiaoming Xie. Their work appears in journals such as Frontiers in Immunology, Journal of Cellular and Molecular Medicine, Aging, BMC Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.